argenx SE has a consensus price target of $450.04, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from Wedbush, Wedbush, and HC Wainwright & Co. on July 1, 2024, June 26, 2024, and June 26, 2024. With an average price target of $509.33 between Wedbush, Wedbush, and HC Wainwright & Co., there's an implied 16.96% upside for argenx SE from these 3 analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/01/2024 | Buy Now | 19.18% | Wedbush | David Nierengarten | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert |
06/26/2024 | Buy Now | 19.18% | Wedbush | David Nierengarten | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert |
06/26/2024 | Buy Now | 12.52% | HC Wainwright & Co. | Douglas Tsao | $448 → $490 | Maintains | Buy | Get Alert |
06/25/2024 | Buy Now | 10.22% | Truist Securities | Joon Lee | $440 → $480 | Maintains | Buy | Get Alert |
06/24/2024 | Buy Now | 39.38% | B of A Securities | Tazeen Ahmad | $535 → $607 | Reiterates | Buy → Buy | Get Alert |
06/24/2024 | Buy Now | 14.81% | Stifel | Alex Thompson | $485 → $500 | Maintains | Buy | Get Alert |
06/24/2024 | Buy Now | 22.85% | Piper Sandler | Allison Bratzel | $522 → $535 | Maintains | Overweight | Get Alert |
06/24/2024 | Buy Now | 24.46% | Wells Fargo | Derek Archila | $478 → $542 | Maintains | Overweight | Get Alert |
06/24/2024 | Buy Now | 2.87% | HC Wainwright & Co. | Douglas Tsao | $448 → $448 | Reiterates | Buy → Buy | Get Alert |
06/17/2024 | Buy Now | 19.86% | Piper Sandler | Allison Bratzel | $522 → $522 | Maintains | Overweight | Get Alert |
06/14/2024 | Buy Now | 2.87% | HC Wainwright & Co. | Douglas Tsao | $448 → $448 | Reiterates | Buy → Buy | Get Alert |
05/28/2024 | Buy Now | 17.11% | Morgan Stanley | Matthew Harrison | $515 → $510 | Maintains | Overweight | Get Alert |
05/13/2024 | Buy Now | 14.81% | JP Morgan | James Gordon | $560 → $500 | Maintains | Overweight | Get Alert |
05/10/2024 | Buy Now | 2.87% | HC Wainwright & Co. | Douglas Tsao | $451 → $448 | Maintains | Buy | Get Alert |
05/10/2024 | Buy Now | 7.47% | JMP Securities | Jason Butler | $471 → $468 | Maintains | Market Outperform | Get Alert |
04/18/2024 | Buy Now | 19.64% | Wedbush | David Nierengarten | → $521 | Reiterates | Outperform → Outperform | Get Alert |
04/18/2024 | Buy Now | 3.56% | HC Wainwright & Co. | Douglas Tsao | → $451 | Reiterates | Buy → Buy | Get Alert |
03/27/2024 | Buy Now | 3.56% | HC Wainwright & Co. | Douglas Tsao | $451 → $451 | Maintains | Buy | Get Alert |
03/26/2024 | Buy Now | -6.31% | Scotiabank | George Farmer | $402 → $408 | Maintains | Sector Perform | Get Alert |
03/22/2024 | Buy Now | 8.15% | JMP Securities | Jason Butler | → $471 | Reiterates | Market Outperform → Market Outperform | Get Alert |
03/05/2024 | Buy Now | 1.04% | Truist Securities | Joon Lee | $370 → $440 | Maintains | Buy | Get Alert |
03/01/2024 | Buy Now | -7.69% | Scotiabank | George Farmer | $346 → $402 | Maintains | Sector Perform | Get Alert |
03/01/2024 | Buy Now | 8.15% | JMP Securities | Jason Butler | $462 → $471 | Maintains | Market Outperform | Get Alert |
03/01/2024 | Buy Now | 12.52% | Baird | Joel Beatty | $505 → $490 | Maintains | Outperform | Get Alert |
03/01/2024 | Buy Now | 3.56% | HC Wainwright & Co. | Douglas Tsao | → $451 | Reiterates | Buy → Buy | Get Alert |
02/20/2024 | Buy Now | 9.76% | Wells Fargo | Derek Archila | $472 → $478 | Maintains | Overweight | Get Alert |
02/15/2024 | Buy Now | — | Wolfe Research | Andy Chen | — | Initiates | → Peer Perform | Get Alert |
01/26/2024 | Buy Now | 19.86% | Piper Sandler | Allison Bratzel | $518 → $522 | Maintains | Overweight | Get Alert |
01/18/2024 | Buy Now | 18.95% | Piper Sandler | Allison Bratzel | $515 → $518 | Maintains | Overweight | Get Alert |
12/21/2023 | Buy Now | 0.12% | Evercore ISI Group | Gavin Clark-Gartner | $594 → $436 | Maintains | Outperform | Get Alert |
12/21/2023 | Buy Now | -20.55% | Scotiabank | George Farmer | $444 → $346 | Maintains | Sector Perform | Get Alert |
12/21/2023 | Buy Now | -15.04% | Truist Securities | Joon Lee | $550 → $370 | Maintains | Buy | Get Alert |
12/21/2023 | Buy Now | 18.26% | Piper Sandler | Allison Bratzel | $575 → $515 | Maintains | Overweight | Get Alert |
12/21/2023 | Buy Now | 7.92% | Wells Fargo | Derek Archila | $585 → $470 | Maintains | Overweight | Get Alert |
12/21/2023 | Buy Now | 3.56% | HC Wainwright & Co. | Douglas Tsao | $582 → $451 | Maintains | Buy | Get Alert |
12/21/2023 | Buy Now | 19.41% | Raymond James | Danielle Brill | $580 → $520 | Maintains | Strong Buy | Get Alert |
12/20/2023 | Buy Now | 26.29% | Truist Securities | Joon Lee | → $550 | Reiterates | Buy → Buy | Get Alert |
12/18/2023 | Buy Now | 28.59% | Stifel | Alex Thompson | $557 → $560 | Maintains | Buy | Get Alert |
12/12/2023 | Buy Now | 47.19% | TD Cowen | Yaron Werber | $612 → $641 | Maintains | Outperform | Get Alert |
12/05/2023 | Buy Now | 28.59% | JP Morgan | James Gordon | $615 → $560 | Maintains | Overweight | Get Alert |
11/30/2023 | Buy Now | 34.56% | Morgan Stanley | Matthew Harrison | $607 → $586 | Maintains | Overweight | Get Alert |
11/29/2023 | Buy Now | 26.29% | Truist Securities | Joon Lee | $570 → $550 | Maintains | Buy | Get Alert |
11/29/2023 | Buy Now | 35.71% | Citigroup | Samantha Semenkow | $610 → $591 | Maintains | Buy | Get Alert |
11/29/2023 | Buy Now | 33.64% | HC Wainwright & Co. | Douglas Tsao | $595 → $582 | Maintains | Buy | Get Alert |
11/29/2023 | Buy Now | 33.18% | Raymond James | Danielle Brill | $600 → $580 | Maintains | Strong Buy | Get Alert |
11/01/2023 | Buy Now | 30.89% | Truist Securities | Joon Lee | → $570 | Reiterates | Buy → Buy | Get Alert |
11/01/2023 | Buy Now | 39.38% | Morgan Stanley | Matthew Harrison | $604 → $607 | Maintains | Overweight | Get Alert |
10/02/2023 | Buy Now | 30.89% | Truist Securities | Joon Lee | → $570 | Reiterates | Buy → Buy | Get Alert |
09/18/2023 | Buy Now | 36.63% | HC Wainwright & Co. | Douglas Tsao | → $595 | Reiterates | Buy → Buy | Get Alert |
08/31/2023 | Buy Now | 37.78% | Piper Sandler | Allison Bratzel | $595 → $600 | Maintains | Overweight | Get Alert |
07/31/2023 | Buy Now | 18.49% | Scotiabank | George Farmer | → $516 | Initiates | → Sector Perform | Get Alert |
07/28/2023 | Buy Now | 35.48% | Guggenheim | Yatin Suneja | $545 → $590 | Maintains | Buy | Get Alert |
07/28/2023 | Buy Now | 39.84% | Wells Fargo | Derek Archila | $606 → $609 | Maintains | Overweight | Get Alert |
07/28/2023 | Buy Now | 36.63% | HC Wainwright & Co. | Douglas Tsao | → $595 | Reiterates | Buy → Buy | Get Alert |
07/24/2023 | Buy Now | 32.04% | Piper Sandler | Allison Bratzel | $545 → $575 | Maintains | Overweight | Get Alert |
07/24/2023 | Buy Now | 30.89% | UBS | Xian Deng | $480 → $570 | Downgrade | Buy → Neutral | Get Alert |
07/21/2023 | Buy Now | 36.63% | HC Wainwright & Co. | Douglas Tsao | $494 → $595 | Maintains | Buy | Get Alert |
07/20/2023 | Buy Now | 38.24% | Morgan Stanley | Matthew Harrison | $452 → $602 | Maintains | Overweight | Get Alert |
07/18/2023 | Buy Now | 35.94% | Citigroup | Samantha Semenkow | $450 → $592 | Maintains | Buy | Get Alert |
07/18/2023 | Buy Now | 25.15% | Guggenheim | Yatin Suneja | $505 → $545 | Maintains | Buy | Get Alert |
07/18/2023 | Buy Now | 30.89% | Wedbush | David Nierengarten | → $570 | Reiterates | Outperform → Outperform | Get Alert |
07/18/2023 | Buy Now | 37.78% | Raymond James | Danielle Brill | $460 → $600 | Maintains | Strong Buy | Get Alert |
07/18/2023 | Buy Now | 13.44% | HC Wainwright & Co. | Douglas Tsao | → $494 | Reiterates | Buy → Buy | Get Alert |
07/17/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao | — | Reiterates | Buy → Buy | Get Alert |
07/17/2023 | Buy Now | 17.8% | Jefferies | Akash Tewari | $497 → $513 | Maintains | Buy | Get Alert |
07/17/2023 | Buy Now | 0.12% | Evercore ISI Group | Gavin Clark-Gartner | → $436 | Reinstates | → Outperform | Get Alert |
06/22/2023 | Buy Now | 13.44% | HC Wainwright & Co. | Douglas Tsao | → $494 | Reiterates | Buy → Buy | Get Alert |
06/21/2023 | Buy Now | 4.25% | Wedbush | David Nierengarten | → $454 | Reiterates | Outperform → Outperform | Get Alert |
06/21/2023 | Buy Now | 13.44% | HC Wainwright & Co. | Douglas Tsao | → $494 | Reiterates | Buy → Buy | Get Alert |
06/07/2023 | Buy Now | 13.44% | HC Wainwright & Co. | Douglas Tsao | → $494 | Reiterates | Buy → Buy | Get Alert |
05/31/2023 | Buy Now | 10.22% | UBS | Xian Deng | → $480 | Initiates | → Buy | Get Alert |
05/05/2023 | Buy Now | 3.79% | Morgan Stanley | Matthew Harrison | $450 → $452 | Maintains | Overweight | Get Alert |
05/05/2023 | Buy Now | 1.04% | Truist Securities | Joon Lee | $420 → $440 | Maintains | Buy | Get Alert |
05/05/2023 | Buy Now | 2.18% | JMP Securities | Jason Butler | $448 → $445 | Maintains | Market Outperform | Get Alert |
05/05/2023 | Buy Now | 13.44% | HC Wainwright & Co. | Douglas Tsao | $482 → $494 | Maintains | Buy | Get Alert |
05/05/2023 | Buy Now | 5.63% | Raymond James | Danielle Brill | $455 → $460 | Maintains | Strong Buy | Get Alert |
05/03/2023 | Buy Now | 10.68% | HC Wainwright & Co. | Douglas Tsao | → $482 | Reiterates | → Buy | Get Alert |
04/25/2023 | Buy Now | 3.33% | Citigroup | Samantha Semenkow | → $450 | Initiates | → Buy | Get Alert |
04/21/2023 | Buy Now | -0.8% | Wedbush | David Nierengarten | → $432 | Reiterates | → Outperform | Get Alert |
03/20/2023 | Buy Now | 10.68% | HC Wainwright & Co. | Douglas Tsao | $480 → $482 | Maintains | Buy | Get Alert |
03/03/2023 | Buy Now | -0.11% | SVB Leerink | Thomas Smith | $430 → $435 | Maintains | Outperform | Get Alert |
03/03/2023 | Buy Now | 2.87% | JMP Securities | Roy Buchanan | $443 → $448 | Maintains | Market Outperform | Get Alert |
03/03/2023 | Buy Now | 10.22% | HC Wainwright & Co. | Douglas Tsao | → $480 | Reiterates | → Buy | Get Alert |
02/23/2023 | Buy Now | 9.07% | Piper Sandler | Allison Bratzel | $465 → $475 | Maintains | Overweight | Get Alert |
01/25/2023 | Buy Now | 5.17% | Cowen & Co. | Yaron Werber | $441 → $458 | Maintains | Outperform | Get Alert |
01/10/2023 | Buy Now | 10.22% | HC Wainwright & Co. | Douglas Tsao | $440 → $480 | Maintains | Buy | Get Alert |
12/22/2022 | Buy Now | 9.76% | Stifel | Alex Thompson | $471 → $478 | Maintains | Buy | Get Alert |
12/07/2022 | Buy Now | — | William Blair | Myles Minter | — | Initiates | → Outperform | Get Alert |
10/28/2022 | Buy Now | 3.33% | Morgan Stanley | Matthew Harrison | $401 → $450 | Maintains | Overweight | Get Alert |
10/28/2022 | Buy Now | -3.56% | Truist Securities | Joon Lee | $410 → $420 | Maintains | Buy | Get Alert |
10/28/2022 | Buy Now | 1.04% | HC Wainwright & Co. | Douglas Tsao | $425 → $440 | Maintains | Buy | Get Alert |
10/28/2022 | Buy Now | -1.26% | SVB Leerink | Thomas Smith | $428 → $430 | Maintains | Outperform | Get Alert |
10/18/2022 | Buy Now | 7.69% | Wells Fargo | Derek Archila | $461 → $469 | Maintains | Overweight | Get Alert |
10/12/2022 | Buy Now | — | Oppenheimer | Leland Gershell | — | Initiates | → Perform | Get Alert |
08/26/2022 | Buy Now | 6.78% | Piper Sandler | Allison Bratzel | $450 → $465 | Maintains | Overweight | Get Alert |
07/29/2022 | Buy Now | -2.41% | HC Wainwright & Co. | Douglas Tsao | $400 → $425 | Maintains | Buy | Get Alert |
07/29/2022 | Buy Now | -7.92% | Morgan Stanley | Matthew Harrison | $375 → $401 | Maintains | Overweight | Get Alert |
07/29/2022 | Buy Now | 5.63% | Baird | Joel Beatty | $374 → $460 | Downgrade | Outperform → Neutral | Get Alert |
07/29/2022 | Buy Now | -1.72% | SVB Leerink | Thomas Smith | $404 → $428 | Maintains | Outperform | Get Alert |
07/25/2022 | Buy Now | -2.41% | Piper Sandler | Allison Bratzel | $415 → $425 | Maintains | Overweight | Get Alert |
The latest price target for argenx (NASDAQ:ARGX) was reported by Wedbush on July 1, 2024. The analyst firm set a price target for $519.00 expecting ARGX to rise to within 12 months (a possible 19.18% upside). 66 analyst firms have reported ratings in the last year.
The latest analyst rating for argenx (NASDAQ:ARGX) was provided by Wedbush, and argenx reiterated their outperform rating.
There is no last upgrade for argenx
The last downgrade for argenx SE happened on July 24, 2023 when UBS changed their price target from $480 to $570 for argenx SE.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of argenx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for argenx was filed on July 1, 2024 so you should expect the next rating to be made available sometime around July 1, 2025.
While ratings are subjective and will change, the latest argenx (ARGX) rating was a reiterated with a price target of $519.00 to $519.00. The current price argenx (ARGX) is trading at is $435.49, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.